je.st
news
Home
› Results from Active Biotech's Phase II/III Anyara trial for the treatment of renal cell cancer
Results from Active Biotech's Phase II/III Anyara trial for the treatment of renal cell cancer
2013-01-28 09:44:18| Biotech - Topix.net
Active Biotech announced today the initial results from the ANYARA Phase II/III clinical study.
Tags: results
active
cell
treatment
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||